Early MS treatments differ most in relapses and MRI lesions, not disability
For people recently diagnosed with multiple sclerosis (MS), early treatment choices were associated with only slight differences after two years, based on the first treatment they used, according to a study published Sept. 9, 2026, in Neurology Open Access. The study found that B-cell-depleting therapies, which are given through an infusion in a vein and lower the number of B cells, a type of…
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
